Das Erysipel ist eine klassische Blickdiagnose. Bei welchen Symptomen müssen Sie eine weiterführende Diagnostik veranlassen? Welche Antibiotika sind zu Beginn, welche bei kompliziertem Verlauf empfehlenswert?
Literatur
Kilburn SA, Featherstone P, Higgins B, Brindle R. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev 2010:CD004299.
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59:e10–52.
Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA 2016;316:325–37.
Dalal A, Eskin-Schwartz M, Mimouni D, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev 2017;6:CD009758.
Ferreira A, Bolland MJ, Thomas MG. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas. Infection 2016;44:607–15.
Bodmann K-F, Grabein B, Kresken M, et al. S2k Leitlinie: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen —Update 2018. Paul-Ehrlich-Gesellschaft, verfügbar unter http://wwwawmforg/uploads/tx_szleitlinien/S82-006l_S2k_Parenterale_Antibiotika_2018-1pdf, 2018.
Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J. A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection. Clin Infect Dis 2016;62:545–51.
Bergkvist PI, Sjobeck K. Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. Scand J Infect Dis 1997;29:377–82.
Dall L, Peterson S, Simmons T, Dall A. Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy. Cutis 2005;75:177–80.
Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas—risk factors and clinical presentation. BMC Infect Dis 2014;14:270.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seybold, U., Stubbe, H., Draenert, R. et al. Erysipel: Wann wird es kritisch?. MMW - Fortschritte der Medizin 160, 37–40 (2018). https://doi.org/10.1007/s15006-018-0580-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-018-0580-3